Table 2.
Pharmacokinetic parameter | Sublingual fentanyl wafer (n = 11)
|
Intravenous fentanyl (n = 12) | |
---|---|---|---|
Dry mouth (n = 5) | Wet mouth (n = 6) | ||
AUCinf (ng/mL/min), median | 16.7 (15.2) | 20.4 (19.8) | 38.5 (32.4) |
AUCt (ng/mL/min), median | NA | 15.2 (14.5) | 27.7 (20.8) |
tfirst (min), median | 30 (15) | 3.5 (8.8) | NA |
Cmax (ng/mL), median | 0.11 (0.08) | 0.12 (0.11) | 0.87 (0.69) |
tmax (min), median | 67 (60) | 61.5 (60) | 2 (2) |
t1/2 (h), median | NA | 4.9 (3.4) | 1.7 (1.5) |
Bioavailability (%) using AUCinf | NA | 53.0 | NA |
Abbreviations: AUC, area under the concentration-time curve; NA, not applicable; IQR, interquartile range.